# Bioavailability Study of Amitriptyline Hydrochloride Tablets

> **NCT03646526** · PHASE1 · COMPLETED · sponsor: **First Affiliated Hospital of Zhejiang University** · enrollment: 60 (actual)

## Conditions studied

- Depressive Disorder

## Interventions

- **DRUG:** Amitriptyline Hydrochloride 25Mg Tablet（Hunan Dongting）
- **DRUG:** Amitriptyline Hydrochloride 25Mg Tablet（Sandoz）

## Key facts

- **NCT ID:** NCT03646526
- **Lead sponsor:** First Affiliated Hospital of Zhejiang University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-04-04
- **Primary completion:** 2019-01-31
- **Final completion:** 2019-01-31
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2019-08-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03646526

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03646526, "Bioavailability Study of Amitriptyline Hydrochloride Tablets". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT03646526. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*